Table of Contents Author Guidelines Submit a Manuscript
Journal of Pharmaceutics
Volume 2013 (2013), Article ID 517638, 7 pages
http://dx.doi.org/10.1155/2013/517638
Research Article

Antibacterial Derivatives of Ciprofloxacin to Inhibit Growth of Necrotizing Fasciitis Associated Penicillin Resistant Escherichia coli

1University of Nebraska, College of Arts & Sciences, Durham Science Center, Department of Chemistry, Omaha, NE 68182, USA
2Texas A & M Health Science Center, Department of Microbial and Molecular Pathogenesis, Bryan, TX 77807, USA

Received 7 December 2012; Revised 9 April 2013; Accepted 10 April 2013

Academic Editor: Anna Wesolowska

Copyright © 2013 Ronald Bartzatt et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. A. Fontes, C. M. Ogilvie, and T. Miclau, “Necrotizing soft-tissue infections,” The Journal of the American Academy of Orthopaedic Surgeons, vol. 8, no. 3, pp. 151–158, 2000. View at Google Scholar · View at Scopus
  2. B. Sarani, M. Strong, J. Pascual, and C. W. Schwab, “Necrotizing fasciitis: current concepts and review of the literature,” Journal of the American College of Surgeons, vol. 208, no. 2, pp. 279–288, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. J. D. Urshel, “Necrotizing soft tissue infections,” Postgraduate Medical Journal, vol. 75, pp. 645–649, 1999. View at Publisher · View at Google Scholar
  4. H. Shaked, Z. Samra, M. Paul et al., “Unusual “flesh-eating” strain of Escherichia coli,” Journal of Clinical Microbiology, vol. 48, no. 10, pp. 3794–3796, 2010. View at Publisher · View at Google Scholar
  5. D. M. Li, L. D. Lun, and X. R. Chun, “Necrotising fasciitis with Escherichia coli,” The Lancet Infectious Diseases, vol. 6, no. 7, pp. 456–459, 2006. View at Publisher · View at Google Scholar
  6. V. B. D. G. Salvador, M. D. S. Juan, J. A. Salisi, and R. J. Consunji, “Clinical and microbiological spectrum of necrotizing fasciitis in surgical patients at a Philippine university medical centre,” Asian Journal of Surgery, vol. 33, no. 1, pp. 51–58, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. R. Muqim, “Necrotizing fasciitis: management and outcome,” Journal of the College of Physicians and Surgeons Pakistan, vol. 13, no. 12, pp. 711–714, 2003. View at Google Scholar · View at Scopus
  8. C. Lee and C. Oh, “Necrotizing fasciitis of genitalia,” Urology, vol. 13, no. 6, pp. 604–606, 1979. View at Google Scholar · View at Scopus
  9. H. Van de Waterbeemd, G. Camenisch, G. Folkers, and O. A. Raevsky, “Estimation of Caco-2 cell permeability using calculated molecular descriptors,” Quantitative Structure-Activity Relationships, vol. 15, no. 6, pp. 480–490, 1996. View at Publisher · View at Google Scholar · View at Scopus
  10. D. E. Clark, “Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 1. Prediction of intestinal absorption,” Journal of Pharmaceutical Sciences, vol. 88, no. 8, pp. 807–814, 1999. View at Publisher · View at Google Scholar · View at Scopus
  11. P. Ertl, B. Rohde, and P. Selzer, “Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties,” Journal of Medicinal Chemistry, vol. 43, no. 20, pp. 3714–3717, 2000. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Majeski and E. Majeski, “Necrotizing fasciitis: improved survival with early recognition by tissue biopsy and aggressive surgical treatment,” Southern Medical Journal, vol. 90, no. 11, pp. 1065–1068, 1997. View at Google Scholar · View at Scopus
  13. L. R. Wiseman and J. A. Balfour, “Ciprofloxacin. A review of its pharmacological profile and therapeutic use in the elderly,” Drugs and Aging, vol. 4, no. 2, pp. 145–173, 1994. View at Google Scholar · View at Scopus
  14. A. Acharya, R. Gurung, B. Khanal, and A. Ghimire, “Bacteriology and antibiotic susceptibility pattern of peritonsillar abscess,” Journal of the Nepal Medical Association, vol. 49, no. 178, pp. 139–142, 2010. View at Google Scholar · View at Scopus
  15. D. Longo, A. Fauci, D. Kasper et al., Principles of Internal Medicine, McGraw-Hill Company, New York, NY, USA, 18th edition, 2011.
  16. C. A. Lipinski, F. Lombardo, B. W. Dominy, and P. J. Feeney, “Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings,” Advanced Drug Delivery Reviews, vol. 23, no. 1-3, pp. 3–25, 1997. View at Publisher · View at Google Scholar · View at Scopus
  17. H. A. Bensen and A. C. Watkinson, Topical and Transdermal Drug Delivery, John Wiley & Sons, New York, NY, USA, 2012.
  18. A. R. Katritzky, D. A. Dobchev, D. C. Fara et al., “Skin permeation rate as a function of chemical structure,” Journal of Medicinal Chemistry, vol. 49, no. 11, pp. 3305–3314, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. G. L. Flynn, Principles of Route-to-Route Extrapolation for Risk Assessment, Elsevier, New York, NY, USA, 1990.
  20. D. E. Clark, “Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 2. Prediction of blood-brain barrier penetration,” Journal of Pharmaceutical Sciences, vol. 88, no. 8, pp. 815–821, 1999. View at Publisher · View at Google Scholar · View at Scopus
  21. N. Boyd and M. D. Nailor, “Combination antibiotic therapy for empiric and definitive treatment of gram-negative infections: insights from the society of infectious diseases pharmacists,” Pharmacotherapy, vol. 31, no. 11, pp. 1073–1084, 2011. View at Google Scholar
  22. D. M. Livermore, “The need for new antibiotics,” Clinical Microbiology and Infection, vol. 10, 4, pp. 1–9, 2004. View at Google Scholar
  23. R. Bartzatt, S. L. G. Cirillo, and J. D. Cirillo, “Design of ciprofloxacin derivatives that inhibit growth of methicillin resistant staphylococcus aureus (MRSA) and methicillin susceptible staphylococcus aureus (MSSA),” Medicinal Chemistry, vol. 6, no. 2, pp. 51–56, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. R. Bartzatt, S. L. Cirillo, and J. D. Cirillo, “Antibacterial agents inhibiting growth of ampicillin resistant Escherichia coli,” Current Trends in Medicinal Chemistry. In press.
  25. L. Aguilar, M. J. Gimenez, C. Garcia-Rey et al., “New strategies to overcome antimicrobial resistance in Streptococcus pneumoniae with β-lactam antibiotics,” Journal of Antimicrobial Chemotherapy, vol. 50, S2, pp. 93–100, 2002. View at Publisher · View at Google Scholar
  26. S. H. Zinner, “The search for new antimicrobials: why we need new options,” Expert Review of Anti-Infective Therapy, vol. 3, no. 6, pp. 907–913, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. M. A. Fakhree, D. R. Delgado, F. Martínez, and A. Jouyban, “The importance of dielectric constant for drug solubility prediction in binary solvent mixtures: electrolytes and zwitterions in water+ethanol,” AAPS PharmSciTech, vol. 11, no. 4, pp. 1726–1729, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. T. Thorsteinsson, M. Masson, and T. Loftsson, “Dermal delivery of ETH-615, a zwitterionic drug,” Drug Development and Industrial Pharmacy, vol. 26, no. 7, pp. 709–714, 2000. View at Publisher · View at Google Scholar · View at Scopus
  29. T. Hatanaka, T. Kamon, C. Uozumi et al., “Influence of pH on skin permeation of amino acids,” Journal of Pharmacy and Pharmacology, vol. 48, no. 7, pp. 675–679, 1996. View at Google Scholar · View at Scopus
  30. R. A. Scherrer and S. M. Howard, “Use of distribution coefficients in quantitative structure-activity relationships,” Journal of Medicinal Chemistry, vol. 20, no. 1, pp. 53–58, 1977. View at Google Scholar · View at Scopus
  31. S. H. Hilal, S. W. Karickhoff, and L. A. Carreira, “Prediction of the solubility, activity coefficient and liquid/liquid partition coefficient of organic compounds,” QSAR and Combinatorial Science, vol. 23, no. 9, pp. 709–720, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. S. K. Bhal, K. Kassam, I. G. Peirson, and G. M. Pearl, “The rule of five revisited: applying log D in place of log P in drug-likeness filters,” Molecular Pharmaceutics, vol. 4, no. 4, pp. 556–560, 2007. View at Publisher · View at Google Scholar · View at Scopus